Buy Aeglea BioTherapeutics Stock | AGLE Stock Price & Latest News | Public
AGLE

Aeglea BioTherapeutics

$0.00 (0.00%)Today

    About AGLE

    Aeglea Biotherapeutics, Inc. operates as a clinical-stage biotechnology company, which develops next-generation human enzyme therapeutics as disruptive solutions for rare and other high-burden diseases. Its product pegzilarginase, is in a Phase 3 pivotal trial for the t...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Events

    List of events that could affect this stock.

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.25
    -0.49
    -0.74
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$0.39

    Actual EPS
    Q3 2020

    Stats

    Market Cap$321,56M
    Volume10,19k
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$11.38
    1 Year Low$3.50
    Open$7.32
    High$7.32
    Low$6.86

    Buy any stock with any amount of money.

    Download the App
    Download the app